Does ROMOSOZUMAB-AQQG Cause Hypercalcaemia? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Hypercalcaemia have been filed in association with ROMOSOZUMAB-AQQG. This represents 0.2% of all adverse event reports for ROMOSOZUMAB-AQQG.
24
Reports of Hypercalcaemia with ROMOSOZUMAB-AQQG
0.2%
of all ROMOSOZUMAB-AQQG reports
2
Deaths
9
Hospitalizations
How Dangerous Is Hypercalcaemia From ROMOSOZUMAB-AQQG?
Of the 24 reports, 2 (8.3%) resulted in death, 9 (37.5%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Hypercalcaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROMOSOZUMAB-AQQG. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does ROMOSOZUMAB-AQQG Cause?
Fall (646)
Fracture (612)
Arthralgia (517)
Injection site pain (490)
Bone density abnormal (454)
Off label use (419)
Hospitalisation (381)
Headache (360)
Product storage error (348)
Death (263)
What Other Drugs Cause Hypercalcaemia?
RITUXIMAB (857)
METHOTREXATE (803)
ADALIMUMAB (663)
TOCILIZUMAB (618)
ABATACEPT (612)
ETANERCEPT (602)
DENOSUMAB (599)
ALENDRONATE (594)
INFLIXIMAB (594)
LEFLUNOMIDE (585)
Which ROMOSOZUMAB-AQQG Alternatives Have Lower Hypercalcaemia Risk?
ROMOSOZUMAB-AQQG vs ROPEGINTERFERON ALFA-2B-NJFT
ROMOSOZUMAB-AQQG vs ROPINIROLE
ROMOSOZUMAB-AQQG vs ROPIVACAINE
ROMOSOZUMAB-AQQG vs ROSIGLITAZONE
ROMOSOZUMAB-AQQG vs ROSUVASTATIN